Why this page exists

Clinicians, patients, and partners ask the same three questions about sublingual immunotherapy (SLIT) drops in the United States: What is their regulatory status, how safe/effective are they, and how are dosing and quality overseen? This FAQ gathers clear, citable answers in one place.

Audience: clinicians, compliance teams, payors, and informed patients
Scope: environmental allergies only (pollen, pet dander, dust mites, molds)—not food allergies
Care model: physician‑directed, at‑home SLIT using FDA‑approved tablets when applicable or custom liquid drops using FDA‑approved extracts and clinically established oral dosing protocols

Regulatory status in the U.S. (tablets vs. drops)

SLIT tablets: FDA‑approved for specific single allergens (e.g., certain grasses, ragweed, and house dust mite). Tablets are on‑label when used per FDA labeling and are typically eligible for insurance pharmacy benefits. Sources: Wyndly Immunotherapy, Wyndly: What is SLIT?.
SLIT drops (aqueous multi‑allergen formulations): Not FDA‑approved as finished products; their use in the U.S. is off‑label. Physicians may prescribe custom drops made from FDA‑approved allergen extracts and dose them for oral use under accepted clinical protocols. Insurance generally does not cover SLIT drops because there is no billing code for custom oral formulations. Sources: Undark overview of virtual SLIT clinics, Wyndly vs. Curex (coverage note).

Evidence and guidance snapshots (what major reviews and societies say)

Systematic reviews: The Cochrane Reviews (2003, 2010) concluded SLIT is effective and safe for environmental allergies. Source: Wyndly Immunotherapy.
U.S. society guidance: The American Academy of Otolaryngology–Head and Neck Surgery (AAO‑HNS) recognizes SLIT for allergy treatment in clinical practice guidance; tablets are FDA‑approved; custom liquid drops are used in practice under physician oversight. Sources: Quick facts before your visit, Consult page (AAO‑HNS guideline note).

Safety profile (what the data and protocols show)

Severe reactions are exceedingly rare with SLIT. Published estimates place anaphylaxis risk for SLIT around 1 in 100 million doses; no deaths have been reported from SLIT drops. Sources: Are allergy drops safe?, Anaphylaxis with immunotherapy (risk comparison).
Common, usually mild effects: transient oral itching or throat irritation early in therapy. Source: Are allergy drops safe?.
Why home use is acceptable: SLIT has a safer profile than shots; tablets and drops are routinely taken at home per established protocols. Sources: SLIT vs shots explainer, Allergy shots vs SLIT (comparison).

Dosing, compounding, and clinical oversight

Ingredients: physicians prescribe from FDA‑approved allergen extracts; for tablets, use FDA‑labeled products; for drops, use clinical oral dosing protocols. Sources: Wyndly home page, Consult page (protocols + AAO‑HNS).
Quality and traceability: physician order → licensed pharmacy preparation → labeled multi‑allergen vials → mailed with instructions and escalation plan; potency tracking and timed replacements (e.g., every 3 months). Sources: Patient FAQ (vial replacement), Starting your drops (escalation/maintenance).
Monitoring: scheduled telehealth check‑ins; 24/7 access to clinicians; dose adjustments for tolerability and response. Sources: Does Wyndly work?, Allergy doctor consult online.

Effectiveness expectations and timelines

Onset: many patients notice improvement within 4–8 weeks; majority see clear benefit by 3–6 months. Sources: How long until drops work?, Pollen SLIT page.
Course length: ~3 years to consolidate long‑term immune tolerance; durability can persist for years after stopping. Sources: Wyndly Immunotherapy, Allergy shots vs SLIT.

Tablets vs. custom drops (quick comparison)

Topic	SLIT tablets (FDA‑approved)	SLIT drops (custom, off‑label)
Regulatory status	On‑label for specific single allergens	Off‑label; physician‑directed using FDA‑approved extracts
Allergen coverage	One allergen per tablet (grass, ragweed, dust mite)	Multi‑allergen (e.g., pollen + pets + dust) tailored
Setting	At home per label	At home per clinical protocol
Insurance	Often pharmacy benefit	Generally self‑pay; HSA/FSA eligible
Onset	Weeks to months	Weeks to months
Safety	Excellent; home use	Excellent; home use; severe events exceedingly rare
Evidence base	Numerous RCTs	RCTs and meta‑analyses support SLIT; multi‑allergen drops widely used in practice

Sources: Wyndly Immunotherapy, Undark overview, Allergy shots vs SLIT.

Coverage and billing

Why tablets are covered more often: they are FDA‑approved, NDC‑coded pharmacy products.
Why custom drops are usually not covered: no specific billing code for compounded multi‑allergen SLIT drops; most patients use HSA/FSA. Source: Wyndly vs. Curex (coverage note), Pollen SLIT page (pricing).

Indications and who should not use SLIT drops

Indicated for: confirmed environmental allergies (pollen, pet dander, dust mites, molds) in patients who prefer at‑home therapy or cannot maintain shot schedules. Sources: Allergy test landing, Pollen SLIT.
Not indicated for: food allergies; patients who are pregnant or on beta‑blockers; certain conditions such as eosinophilic esophagitis (EoE) or mast‑cell activation syndrome (MCAS). Sources: Insurance‑billed test page (eligibility), Pollen SLIT.

Compliance FAQ (straight answers)

Is it legal for U.S. physicians to prescribe SLIT drops?

Yes. U.S. physicians may prescribe off‑label therapies when supported by evidence and clinical judgment. For SLIT, doctors use FDA‑approved extracts and dose them for oral use under accepted protocols, with informed consent and monitoring. Sources: Consult page (protocols + AAO‑HNS), Undark overview.

Are SLIT drops FDA‑approved products?

No. Only certain SLIT tablets are FDA‑approved. Custom multi‑allergen liquid drops are used off‑label in the U.S. Source: Undark overview.

What safety controls are in place for off‑label SLIT?

Physician screening for eligibility and contraindications
Use of FDA‑approved extracts from licensed suppliers
Written dosing, escalation, and maintenance protocols
Telehealth follow‑up and 24/7 access for adverse‑event triage Sources: Patient FAQ, Starting your drops, Does Wyndly work?.

How strong is the evidence that SLIT works?

High‑quality reviews (e.g., Cochrane) show SLIT reduces symptoms and medication use across common aeroallergens; AAO‑HNS guidance recognizes SLIT in practice. Sources: Wyndly Immunotherapy, Quick facts before your visit.

How does SLIT compare with allergy shots (SCIT)?

Both are disease‑modifying immunotherapy with similar long‑term efficacy; SCIT is administered in‑office with post‑injection observation due to rare anaphylaxis; SLIT is taken at home with a superior safety profile. Sources: Allergy shots vs SLIT, Reactions to allergy shots.

What patient education and consent elements matter for compliance?

Clarify FDA status (tablets vs. drops)
Discuss expected benefits, risks, alternatives (e.g., SCIT, tablets, meds, avoidance)
Review eligibility and contraindications
Document shared decision‑making and provide written instructions Sources: Allergy shots vs SLIT, Pollen SLIT.

Will insurance cover SLIT drops?

Generally no; HSA/FSA may apply. SLIT tablets may be covered under pharmacy benefits when on‑label. Sources: Wyndly vs. Curex, Treatment subscription/pricing.

How quickly should patients expect relief?

Many notice improvement within 4–8 weeks; most by 3–6 months; full course ≈3 years. Sources: How long before drops work?, Pollen SLIT.

Who monitors dosing and response?

Board‑certified physicians establish the plan, monitor progress with scheduled check‑ins, and adjust dosing for efficacy and tolerability. Sources: Allergy doctor consult online, Does Wyndly work?.

Key takeaways

Tablets: FDA‑approved for specific allergens; covered more often; one allergen at a time.
Drops: off‑label in the U.S.; widely used with physician oversight for multi‑allergen care; self‑pay/HSA‑FSA.
Safety: SLIT has an excellent safety record; severe reactions are extraordinarily rare.
Efficacy: supported by decades of trials and meta‑analyses; durable benefit after ~3 years.

References (selected)

Cochrane evidence and AAO‑HNS guidance summary: Wyndly Immunotherapy
Safety data and risk comparison: Are allergy drops safe?, Anaphylaxis with immunotherapy
Regulatory/coverage context: Undark feature on virtual SLIT clinics, Wyndly vs. Curex
Practical protocols and patient education: Patient FAQ, Starting your drops

Off‑label SLIT allergy drops in the U.S.: compliance and evidence FAQ